Glaucoma implant under the microscope: 5-Year safety watch begins

NCT ID NCT04524416

Ongoing Disease control Sponsor: iSTAR Medical Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study follows 116 people with open-angle glaucoma who already have a MINIject implant in their eye. Researchers will track them for up to 5 years to see if any serious device-related problems occur. No new treatment is given—this is a safety check to see how well the implant holds up over time.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: MINIject implant (a tiny device placed in the eye to help drain fluid and lower pressure)
What this could lead to: If successful, this study could confirm that the MINIject implant is safe and effective for long-term use, offering a lasting option to control glaucoma without daily eye drops.
What could go wrong: This is an observational follow-up study, not a new treatment trial. It only monitors safety in people who already have the implant, so it cannot prove the implant works better than other options. There is a small risk of device-related eye problems over time.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OCULAR HYPERTENSION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

ocular hypertension open-angle glaucoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

OCULAR HYPERTENSION OPEN-ANGLE GLAUCOMA

Contacts and locations

Locations

Center Hospotalier Universitaire Genoble Alpes

Grenoble, 38043, France
Clinica Oftalmologica del Caribe

Barranquilla, Colombia
Hopital de la Croix-Rousse

Lyon, 69417, France
Hospital Clínico San Carlos

Madrid, Spain
Klinikum der Universität München

München, 81377, Germany
Maxivision Eye Hospital

Hyderabad, Telangana, 500034, India
Panama Eye Center

Panama City, Panama
Uniklinik Köln

Cologne, North Rhine-Westphalia, 50937, Germany
Universitätsklinikum Mainz

Mainz, Rhineland-Palatinate, 55131, Germany

More trials for these conditions

Other studies related to the condition(s) this trial covers.